Johnson & Johnson Stock Climbs 0.95% as Trading Volume Plunges 25.21% to $1.02 Billion Ranking 87th in Market Activity

Johnson & Johnson (JNJ) rose 0.95% on August 13, 2025, with a trading volume of $1.02 billion, a 25.21% drop from the previous day’s volume and ranking 87th in market activity. The stock’s performance followed developments in the company’s digital health initiatives, particularly in surgical AI integration.

Shan Jegatheeswaran, J&J’s global head of medtech digital, highlighted challenges in surgical software adoption during a recent interview. A company survey of 700 clinicians across 15 countries revealed that fragmented data and inconsistent interoperability hinder the use of AI in operating rooms (ORs). Hospitals with deployed surgical software currently utilize it in only half of cases, citing cumbersome workflows and limited connectivity. Jegatheeswaran emphasized the need for standardized data frameworks and seamless integration, drawing parallels to the evolution of home entertainment systems into unified, user-friendly platforms.

J&J’s strategy for AI in medical devices focuses on unifying pre- and post-procedure data through platforms like Polyphonic, a digital surgery tool. The company aims to enhance real-time surgical guidance, pattern recognition for training, and workflow efficiency by consolidating data streams. Surgeons, while generally enthusiastic about AI’s potential, express concerns over transparency and usability. J&J’s approach involves co-developing solutions with clinicians to build trust, contrasting with “black box” algorithms that may face skepticism. For its Ottava surgical robot, the company plans to integrate connected, intelligent software to streamline operations, though specific features remain undisclosed.

The strategy of buying the top 500 stocks by daily trading volume and holding them for one day from 2022 to now delivered moderate returns. The CAGR was 6.98%, with a maximum drawdown of 15.46% during the backtest period. The strategy demonstrated steady growth over time, making it a robust choice for investors seeking consistent returns. However, the significant drawdown in mid-2023 highlights the importance of risk management in such a volatile scenario.